As a result of these financings, the company's near-term cash requirements have largely been met. Although the company will likely continue to pursue opportunistic acquisitions, management's focus has shifted to maximizing the exceptional asset base which the company has acquired over the past four years. Integration and biotechnology are expected to be the company's main focus over the next year. Integration of the 33 acquired companies into one unified, customer- oriented team is proceeding nicely. The company's emerging biotechnology program is poised to lead the forage and turfgrass seed sector in product development.
Management expects significant additional biotechnology developments.